DMARD Therapy for Rheumatoid Arthritis in Moradabad – Dr. Kriti Kishore at Jigyasa Hospital
Dr. Kriti Kishore is a rheumatology specialist at Jigyasa Hospital, Moradabad, who evaluates and manages patients with rheumatoid arthritis and other autoimmune conditions requiring DMARD therapy. She specializes in selecting appropriate medications and provides comprehensive monitoring throughout the treatment journey.
Her approach emphasizes early initiation of appropriate DMARD therapy, individualized medication selection, and structured monitoring to ensure optimal long-term outcomes. She explains the treatment process clearly so patients understand their medication, expected timelines, and the importance of consistent follow-up care.
The Medications That Change the Course of Disease, Not Just the Symptoms
When someone is newly diagnosed with rheumatoid arthritis or another autoimmune joint condition, one term almost always comes up early in the conversation: DMARDs, or Disease-Modifying Anti-Rheumatic Drugs. Unlike painkillers, which simply mask symptoms, DMARDs work at a deeper level — they slow down or halt the underlying disease process itself, helping to prevent the joint damage that untreated autoimmune arthritis can cause over time.
At Jigyasa Hospital, Moradabad, our rheumatology department, led by Dr. Kriti Kishore, prescribes and carefully monitors DMARD therapy for patients with rheumatoid arthritis and a range of other autoimmune conditions — because getting this treatment right, both in medication choice and ongoing monitoring, makes a real difference in long-term outcomes. This article explains what DMARDs are, how they work, who needs them, and what patients can expect during treatment at Jigyasa Hospital.
What Are DMARDs?
DMARDs are a category of medications specifically designed to modify the underlying course of autoimmune and inflammatory diseases, rather than simply relieving symptoms. Unlike NSAIDs or pain relievers, which provide temporary relief without affecting the disease process itself, DMARDs work by suppressing or modulating the overactive immune response responsible for driving inflammation and tissue damage.
DMARDs are broadly divided into a few categories:
- • Conventional synthetic DMARDs – Traditional medications, such as methotrexate, sulfasalazine, and hydroxychloroquine, that have been used for decades and remain the foundation of treatment for many autoimmune conditions
- • Biologic DMARDs – Advanced, targeted therapies derived from living cells that block specific components of the immune system (often referred to simply as "biologics")
- • Targeted synthetic DMARDs – Newer oral medications, such as JAK inhibitors, that target specific intracellular pathways involved in the inflammatory process
For most patients starting treatment, conventional synthetic DMARDs — particularly methotrexate — are the first-line approach, with biologic or targeted synthetic DMARDs considered if conventional treatment doesn't achieve adequate disease control.
Why Are DMARDs Important?
Autoimmune joint diseases like rheumatoid arthritis are progressive conditions — without adequate treatment, ongoing inflammation gradually damages cartilage, bone, and surrounding tissue, leading to permanent joint deformity and disability. This is why the timing of DMARD initiation matters so much.
Key reasons DMARDs are central to autoimmune disease management include:
- • Preventing irreversible joint damage – By controlling inflammation early, DMARDs help prevent the structural damage that untreated disease causes
- • The "window of opportunity" – Research consistently shows that starting DMARD treatment early in the disease course leads to significantly better long-term outcomes than delaying treatment
- • Reducing the need for higher-risk medications – Effective DMARD therapy often reduces reliance on long-term corticosteroids, which carry their own risks with prolonged use
- • Improving quality of life – Beyond preventing damage, well-controlled disease means less pain, better function, and greater ability to carry out daily activities
Because of this, Dr. Kriti Kishore emphasizes starting appropriate DMARD therapy as soon as a diagnosis is confirmed, rather than waiting for symptoms to become severe.
Conditions Treated with DMARDs
DMARDs are used across a wide range of autoimmune and inflammatory conditions managed in rheumatology, including:
- • Rheumatoid arthritis – The condition most classically associated with DMARD therapy, where early treatment significantly improves long-term joint outcomes
- • Psoriatic arthritis – Both joint and, in some cases, skin symptoms may respond to DMARD treatment
- • Juvenile idiopathic arthritis – Used in children with persistent joint inflammation to prevent long-term joint damage and growth complications
- • Lupus and other connective tissue diseases – Certain DMARDs, such as hydroxychloroquine, are foundational treatments for lupus
- • Vasculitis and myositis – DMARDs are used to help control inflammation and reduce dependence on long-term corticosteroids
- • Some forms of spondyloarthritis – Conventional DMARDs may have a role in peripheral joint involvement, though axial disease often requires other treatment approaches
The specific DMARD chosen depends on the diagnosis, disease severity, and individual patient factors, which Dr. Kriti Kishore evaluates carefully before starting treatment.
How Are DMARDs Chosen?
Selecting the right DMARD involves considering several factors specific to each patient:
1. Diagnosis and disease pattern
Different autoimmune conditions respond better to specific DMARDs
2. Disease severity and activity
More aggressive disease may warrant a more intensive initial treatment approach, sometimes combining multiple DMARDs
3. Other health conditions
Kidney function, liver function, and other existing medical conditions influence which DMARD is safest and most appropriate
4. Pregnancy planning
Certain DMARDs are not safe during pregnancy, which is an important consideration for women of childbearing age
5. Patient preference and lifestyle
Considerations such as route of administration (oral vs. injectable), monitoring requirements, and personal preferences are discussed as part of shared decision-making
This individualized approach ensures that treatment is tailored not just to the diagnosis, but to the whole patient.
Starting DMARD Therapy: What to Expect
Pre-Treatment Evaluation
Before starting most DMARDs, baseline evaluation typically includes:
- • Blood tests to assess liver function, kidney function, and blood counts
- • Screening for certain infections, depending on the specific medication planned
- • A review of current medications to check for potential interactions
- • Discussion of pregnancy planning, where relevant
How DMARDs Are Taken
Depending on the specific medication, DMARDs may be administered as:
- • Oral tablets – Taken daily or weekly, depending on the medication
- • Weekly injections – Some DMARDs, such as methotrexate, can also be given as a weekly subcutaneous injection, which may reduce certain side effects for some patients
- • Combination therapy – In some cases, more than one conventional DMARD is used together for better disease control
Response Timeline
Conventional DMARDs typically take six to twelve weeks to show their full effect, which is an important point for patients to understand at the outset — noticeable improvement is often gradual rather than immediate, and treatment shouldn't be judged as ineffective too early.
Ongoing Monitoring During DMARD Therapy
Because DMARDs affect the immune system and can, in some cases, affect organ function, regular monitoring is a standard and essential part of treatment:
- • Regular blood tests – Typically checking liver function, kidney function, and blood counts at intervals determined by the specific medication and how long the patient has been on treatment
- • Disease activity assessment – Ongoing evaluation of joint symptoms, function, and inflammatory markers to confirm the treatment is working effectively
- • Side effect monitoring – Watching for medication-specific side effects and adjusting treatment if needed
- • Vaccination review – Ensuring appropriate vaccinations are up to date, since immune-modulating treatment can affect vaccine timing and effectiveness
This structured monitoring allows Dr. Kriti Kishore to catch any issues early, adjust dosing as needed, and ensure treatment remains both safe and effective over the long term.
Managing Side Effects and Concerns
Like all medications, DMARDs can cause side effects, though many patients tolerate them well, particularly with appropriate dose adjustment and monitoring. Common approaches to managing tolerability include:
- • Gradual dose adjustments – Starting at a lower dose and increasing gradually to help minimize side effects
- • Supportive supplementation – For example, folic acid is commonly prescribed alongside methotrexate to help reduce certain side effects
- • Switching administration route – Changing from oral to injectable form of certain medications can improve tolerability for some patients
- • Combination or alternative therapy – If a particular DMARD isn't well tolerated or effective, alternative options can be considered
Patients are encouraged to report side effects promptly rather than stopping medication abruptly, since many tolerability issues can be addressed with adjustments rather than requiring a complete change in treatment approach.
When DMARDs Alone Aren't Enough
For some patients, conventional DMARDs don't achieve adequate disease control even after an appropriate trial period. In these cases, treatment may be escalated to include:
- • Combination conventional DMARD therapy – Using more than one conventional DMARD together
- • Biologic DMARDs – Targeted therapies added to or used instead of conventional DMARDs for patients with inadequate response
- • Targeted synthetic DMARDs – Oral options like JAK inhibitors, considered when biologics aren't suitable or preferred
Dr. Kriti Kishore reassesses treatment response at appropriate intervals and adjusts the approach as needed to ensure disease activity remains well controlled over time.
Why Choose Dr. Kriti Kishore at Jigyasa Hospital?
Successful DMARD therapy depends on careful medication selection, appropriate dosing, and consistent monitoring over time. At Jigyasa Hospital, patients benefit from:
- • A dedicated rheumatology consultation focused on early, appropriate DMARD initiation for autoimmune joint conditions
- • Access to comprehensive diagnostic facilities, including a NABL-accredited laboratory, for baseline and ongoing monitoring
- • Individualized medication selection based on diagnosis, disease severity, and patient-specific factors
- • Structured follow-up protocols to ensure safety and track treatment effectiveness
- • Clear guidance on side effect management and when to seek advice
- • 24/7 emergency care availability
- • Treatment support under Ayushman Bharat PM-JAY empanelment for eligible patients
- • Convenient access for patients across Moradabad, Rampur, Sambhal, Amroha, and Bijnor
Living Well While on DMARD Therapy
Living with autoimmune arthritis while on DMARD therapy requires consistent treatment, regular monitoring, and awareness of important health considerations:
- • Take your medication consistently and exactly as prescribed, even once symptoms improve
- • Attend all scheduled blood tests and follow-up appointments, even when feeling well
- • Report side effects to your doctor rather than stopping medication on your own
- • Discuss pregnancy planning with your rheumatologist before conceiving, since some DMARDs need to be adjusted beforehand
- • Avoid alcohol or limit it as advised, particularly with medications that affect liver function
- • Be patient with the treatment timeline — full benefit often takes several weeks to become apparent
- • Keep a record of your medications and monitoring schedule to help stay on track
Book an Appointment with Dr. Kriti Kishore
Jigyasa Hospital offers specialist rheumatology care for rheumatoid arthritis and autoimmune conditions requiring DMARD therapy under the guidance of Dr. Kriti Kishore. Early diagnosis and appropriate treatment can help prevent joint damage and preserve long-term function.
Near Miglani Cinema, Rampur Road, Moradabad 244001
Call Now
7900903333Frequently Asked Questions (FAQs)
Are DMARDs the same as painkillers?
No. DMARDs work by modifying the underlying autoimmune disease process, while painkillers only provide temporary symptom relief without affecting the disease course. Both may be used together, but they serve different purposes.
How long do I need to take DMARDs?
Most autoimmune conditions require long-term DMARD therapy to maintain disease control, though the specific duration and dosing may be adjusted over time based on how well the disease is controlled.
Why do DMARDs take so long to work?
Conventional DMARDs typically take six to twelve weeks to show their full effect, since they work by gradually modulating the immune system rather than providing immediate symptom relief like painkillers.
Do I need regular blood tests while on DMARDs?
Yes, regular blood monitoring is a standard and important part of DMARD therapy to check for medication-related effects on the liver, kidneys, or blood counts, allowing early detection and management of any issues.
Can I stop taking DMARDs once my symptoms improve?
No, DMARDs should not be stopped without discussing it with your rheumatologist, as disease activity can flare even when symptoms have improved, since the underlying disease process may still be present.
What happens if a DMARD doesn't work for me?
If a conventional DMARD doesn't achieve adequate disease control after an appropriate trial period, your rheumatologist may consider combination therapy, a different DMARD, or escalation to biologic or targeted synthetic therapy.
Why Patients Choose Us
- 24/7 Emergency & Trauma Care
- Top Specialist Doctors
- Modern ICU & Operation Theatres
- Transparent & Affordable Pricing
- Ayushman Bharat Empanelled
- Cashless Insurance Support
- Multispeciality Under One Roof
Our Location
Near Miglani Cinema,
Rampur Road,
Moradabad 244001